Nurix Therapeutics, Inc. (NRIX)
Pharmaceutical Preparations
Latest Price
$24.83
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
3.64
P/B Ratio
6.82
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 8.77M | $212.0M | 8.46% | -155.3K | 2026-06-30 |
| Vestal Point Capital, LP | 8.05M | $195.0M | 7.76% | +1.55M | 2026-06-30 |
| Deep Track Capital, LP | 7.74M | $187.0M | 7.46% | +1.39M | 2026-06-30 |
| Rubric Capital Management LP | 7.23M | $175.0M | 6.97% | +4.75M | 2026-06-30 |
| FMR LLC | 5.49M | $133.0M | 5.29% | -56.1K | 2026-06-30 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 5.44M | $131.0M | 5.24% | +2.15M | 2026-06-30 |
| MORGAN STANLEY | 4.76M | $115.0M | 4.59% | -169.5K | 2026-06-30 |
| STATE STREET CORP | 4.68M | $113.0M | 4.51% | -464.0K | 2026-06-30 |
| BAKER BROS. ADVISORS LP | 4.66M | $113.0M | 4.49% | -- | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.50M | $109.0M | 4.34% | +68.4K | 2026-06-30 |